Bronchioloalveolar carcinoma of mixed mucinous and nonmucinous type: immunohistochemical studies and mutation analysis of the p53 gene.

[1]  N. P. Ohori,et al.  Cytopathologic diagnosis of bronchioloalveolar carcinoma: does it correlate with the 1999 World Health Organization definition? , 2004, American journal of clinical pathology.

[2]  N. Goldstein,et al.  Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies. , 2001, American journal of clinical pathology.

[3]  S. Hirohashi,et al.  Increased expression of laminin‐5 and its prognostic significance in lung adenocarcinomas of small size , 2001, Cancer.

[4]  Y. Takeshima,et al.  Loss of expression of E‐cadherin and β‐catenin is associated with progression of pulmonary adenocarcinoma , 2005, Pathology international.

[5]  S. Hirohashi,et al.  Mixed mucinous-type and non-mucinous-type adenocarcinoma of the lung: immunohistochemical examination and K-ras gene mutation , 2002, Virchows Archiv.

[6]  Y. Takeshima,et al.  Correlation between genetic alterations and histopathological subtypes in bronchiolo‐alveolar carcinoma and atypical adenomatous hyperplasia of the lung , 2000, Pathology international.

[7]  A. Marchetti,et al.  FHIT and p53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K‐ras mutations , 1998, The Journal of pathology.

[8]  Y. Dobashi,et al.  Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter: a prognostic assessment. , 2004, The Annals of thoracic surgery.

[9]  N. P. Ohori,et al.  Cytopathologic Diagnosis of Bronchioloalveolar Carcinoma , 2004 .

[10]  Y. Takeshima,et al.  Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung. , 2004, American journal of clinical pathology.

[11]  K. Sugimachi,et al.  Clinicopathological and molecular evidence indicating the independence of bronchioloalveolar components from other subtypes of human peripheral lung adenocarcinoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  Tesshi Yamada,et al.  Lung Adenocarcinoma With Mixed Bronchioloalveolar and Invasive Components: Clinicopathological Features, Subclassification by Extent of Invasive Foci, and Immunohistochemical Characterization , 2003, The American journal of surgical pathology.

[13]  S. Lau,et al.  Expression of Thyroid Transcription Factor-1, Cytokeratin 7, and Cytokeratin 20 in Bronchioloalveolar Carcinomas: an Immunohistochemical Evaluation of 67 Cases , 2002, Modern Pathology.

[14]  J. Silverman,et al.  Prognostic significance of thyroid transcription factor-1 expression in both early-stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung. , 2004, Human pathology.

[15]  S. Badve,et al.  Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma. , 2002, Human pathology.

[16]  M. Fishbein,et al.  Immunohistochemical analysis of lung carcinomas with pure or partial bronchioloalveolar differentiation. , 2004, Archives of pathology & laboratory medicine.

[17]  T. Nagao,et al.  Expression of E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin in bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma: an immunohistochemical study. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[18]  F. Clayton.  Bronchioloalveolar carcinomas. Cell types, patterns of growth, and prognostic correlates , 1986, Cancer.